Microsaic designs and manufactures bench-top mass spectrometry (MS) technology. Combining patented technology and a collaborative approach to co-development with global purification and separations partners, Microsaic can demonstrate benchtop MS as the technique of choice beyond the traditional analysis market. With over 100 systems already installed, the company’s new management team is focussed on growth opportunities in early drug development and process analytical science across life science markets through IP extension and excellent customer relationship management. The fund-raising announced today will help enable this strategy’s success.
